Tech Company Financing Transactions
Samplix Funding Round
Private investors participated in a $29 million venture round for Samplix. This venture round was announced on 10/28/2026.
Transaction Overview
Company Name
Announced On
10/28/2026
Transaction Type
Venture Equity
Amount
$29,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Samplix intends to use the new capital to strengthen its balance sheet and broaden commercial adoption of the Xdrop platform, particularly in the antibody discovery space. The company also sees a growing opportunity for its platform in AI-driven drug discovery, where large volumes of functional, cell-level data are needed to train predictive models.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Bregnerødvej 96
Birkerød, 3460
DK
Birkerød, 3460
DK
Phone
Website
Email Address
Overview
Samplix ApS develops microfluidics technologies for high-throughput, function-first single-cell analysis. Our solutions help researchers study what individual cells actually do -- not just which markers they express. At the core of our technology is the generation of highly uniform microfluidic double-emulsion droplets. These droplets act as isolated microreactors fully compatible with standard flow cytometers and cell sorters, allowing scientists to integrate droplet-based workflows directly into existing laboratory infrastructure without specialized detection systems.
Management Team
Browse more venture capital transactions:
Prev: 10/28/2026: Loamy Technologies venture capital transaction
Next: 10/28/2026: Golden Age Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








